학술논문

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
Document Type
Article
Source
In The Lancet Oncology September 2020 21(9):1213-1223
Subject
Primary Research
Articles
Language
ISSN
1470-2045